5YIE
Crystal Structure of KNI-10742 bound Plasmepsin II (PMII) from Plasmodium falciparum
Summary for 5YIE
Entry DOI | 10.2210/pdb5yie/pdb |
Descriptor | Plasmepsin II, 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE, (4R)-3-[(2S,3S)-3-[2-[4-[2-azanylethyl(ethyl)amino]-2,6-dimethyl-phenoxy]ethanoylamino]-2-oxidanyl-4-phenyl-butanoyl]-5,5-dimethyl-N-[(1S,2R)-2-oxidanyl-2,3-dihydro-1H-inden-1-yl]-1,3-thiazolidine-4-carboxamide, ... (5 entities in total) |
Functional Keywords | plasmepsin, plasmepsin ii, kni-10742, aspartic protease, plasmodium falciparum, drug development, inhibitor, hydrolase |
Biological source | Plasmodium falciparum (isolate 3D7) (isolate 3D7) |
Total number of polymer chains | 1 |
Total formula weight | 38740.22 |
Authors | Mishra, V.,Rathore, I.,Bhaumik, P. (deposition date: 2017-10-04, release date: 2018-07-11, Last modification date: 2019-05-29) |
Primary citation | Mishra, V.,Rathore, I.,Arekar, A.,Sthanam, L.K.,Xiao, H.,Kiso, Y.,Sen, S.,Patankar, S.,Gustchina, A.,Hidaka, K.,Wlodawer, A.,Yada, R.Y.,Bhaumik, P. Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights. Febs J., 285:3077-3096, 2018 Cited by PubMed: 29943906DOI: 10.1111/febs.14598 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report